These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18327066)

  • 1. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials.
    Coleman CI; Baker WL; Kluger J; White CM
    J Hypertens; 2008 Apr; 26(4):622-9. PubMed ID: 18327066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy and the risk of malignancies.
    Grossman E; Messerli FH; Goldbourt U
    Eur Heart J; 2001 Aug; 22(15):1343-52. PubMed ID: 11465967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and secondary prevention of stroke by antihypertensive drug treatment.
    Wang JG; Li Y
    Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials.
    Tropeano AI; Saleh N; Hawajri N; Macquin-Mavier I; Maison P
    Fundam Clin Pharmacol; 2011 Jun; 25(3):395-404. PubMed ID: 20584209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
    Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
    J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazide diuretics in the treatment of hypertension: an update.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S25-9. PubMed ID: 16565243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.
    Staessen JA; Li Y; Thijs L; Wang JG
    Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.
    Wald DS; Law M; Morris JK; Bestwick JP; Wald NJ
    Am J Med; 2009 Mar; 122(3):290-300. PubMed ID: 19272490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials.
    Segall L; Oprisiu R; Fournier A; Covic A
    J Nephrol; 2008; 21(3):374-83. PubMed ID: 18587726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which, if any, antihypertensive agents cause cancer?
    Singh A; Bangalore S
    Curr Opin Cardiol; 2012 Jul; 27(4):374-80. PubMed ID: 22565138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the impact of 9 medication classes on falls in elderly persons.
    Woolcott JC; Richardson KJ; Wiens MO; Patel B; Marin J; Khan KM; Marra CA
    Arch Intern Med; 2009 Nov; 169(21):1952-60. PubMed ID: 19933955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
    J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.